Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study

• Main Authors: Elvia Cristina Mendoza-Caamal (Author), Francisco Barajas-Olmos (Author), Humberto García-Ortiz (Author), Isabel Cicerón-Arellano (Author), Angélica Martínez-Hernández (Author), Emilio J. Córdova (Author), Marcelino Esparza-Aguilar (Author), Cecilia Contreras-Cubas (Author), Federico Centeno-Cruz (Author), Miguel Cid-Soto (Author), Mirna Edith Morales-Marín (Author), Adriana Reséndiz-Rodríguez (Author), Juan Luis Jiménez-Ruiz (Author), María Guadalupe Salas-Martínez (Author), Yolanda Saldaña-Alvarez (Author), Elaheh Mirzaeicheshmeh (Author), María Rosalba Rojas-Martínez (Author), Lorena Orozco (Author)
• Format: Book
• Published: BMC, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s12889-020-8378-5; 1471-2458
• Keywords: Mexican Amerindian; Indigenous; Metabolic syndrome; Prevalence; HDL-cholesterol; Waist circumference; Public aspects of medicine; RA1-1270
• Source: BMC Public Health, Vol 20, Iss 1, Pp 1-8 (2020)

Abstract Background An Amerindian genetic background could play an important role in susceptibility to metabolic diseases, which have alarmingly increased in recent decades. Mexico has one of the highest prevalences of metabolic disease worldwide. The purpose of this study was to determine the prevalence of metabolic syndrome and its components in a population with high Amerindian ancestry. Methods We performed a descriptive, quantitative, and analytical cross-sectional study of 2596 adult indigenous volunteers from 60 different ethnic groups. Metabolic syndrome and its components were evaluated using the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement criteria. Results The overall prevalence of metabolic syndrome in the indigenous Mexican population was 50.3%. Although females had a higher prevalence than males (55.6% vs. 38.2%), the males presented with combinations of metabolic syndrome components that confer a higher risk of cardiovascular disease. The most frequent metabolic syndrome component in both genders was low HDL-cholesterol levels (75.8%). Central obesity was the second most frequent component in females (61%), though it had a low prevalence in males (16.5%). The overall prevalence of elevated blood pressure was 42.7% and was higher in males than females (48.8 vs. 40%). We found no gender differences in the overall prevalence of elevated triglycerides (56.7%) or fasting glucose (27.9%). Conclusions We documented that individuals with Amerindian ancestry have a high prevalence of metabolic syndrome. Health policies are needed to control the development of metabolic disorders in a population with high genetic risk.